Skip to main content

Our Product Portfolio

Biosimilars

A biosimilar for HUMIRA® (adalimumab)

Abbvie Inc.

A biosimilar for STELARA® (ustekinumab)

Janssen Biotech Inc.

A biosimilar for Actemra® (tocilizumab)

Genentech

A biosimilar for STELARA® (ustekinumab)

Janssen Biotech Inc.

A biosimilar for Xgeva® (denosumab)

Amgen Inc.

A biosimilar for Prolia® (denosumab)

Amgen Inc.

Specialty Products Delivered Safely and Reliably

Specialty Drugs

NDW distributes a curated set of specialty medications across multiple disease states, including:

  • Immunology
  • Oncology supportive care
  • Rheumatology
  • Gastroenterology
  • Neurology
  • Ophthalmology (LDD)
  • Rare and chronic immune disorders

Limited-Distribution Drug (LDD) Infrastructure

Manufacturers rely on NDW for controlled, compliant, high-integrity distribution supported by:

  • Tight channel management
  • Verified dispensing partner networks
  • Real-time utilization reporting
  • National compliant cold-chain logistics
  • Highly credentialed pharmacy partners

Quality, Compliance, and Infrastructure

Licensure and Accreditation

  • National expansion of wholesale licenses
  • DSCSA/serialization compliance
  • Validated standard operating procedures
  • CarePartners accreditation standards and pharmacy quality systems

Technology and EDI

  • Real-time inventory visibility
  • EDI (850/856/810)
  • GLN, GS1, and track-and-trace compliance
  • Integrated ordering portals

Cold-Chain and Logistics

  • Validated 2–8°C packaging
  • Overnight and 2-day shipping
  • Regional courier and national carrier networks
  • Temperature monitoring & documentation

Let’s Build Your
Specialty Distribution Strategy

Whether you are a manufacturer, PBM, payer, pharmacy, provider, or cost-containment partner, NDW is ready to support your specialty mediccation needs.

Explore Partner Solutions
Skip to content